Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
DE-111 Against Timolol Ophthalmic Solution 0.5%
- Status
- COMPLETED
- Phase
- PHASE3
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
- Status
- COMPLETED
- Phase
- PHASE3
Patient Preference Comparison of AZARGA Versus COSOPT
- Status
- COMPLETED
- Phase
- PHASE4
24-hour Efficacy of AR-12286
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Changing to DUOTRAV® From Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
- Status
- TERMINATED
- Phase
- PHASE2
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations
- Status
- COMPLETED
- Phase
- PHASE3
AR-12286 in Combination With Latanoprost
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Divided Dose of TRAVATAN®
- Status
- COMPLETED
- Phase
- PHASE2
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
- Status
- COMPLETED
- Phase
- PHASE3
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE3
Adherence With Fixed Versus Unfixed Glaucoma Therapy
- Status
- COMPLETED
- Phase
- N/A